Compare ARYX to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 2.95 |
|---|---|
| Trade Time: | Feb 9 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 2.95 |
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 6.38 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 1.90 - 6.32 |
| Volume: | 0 |
| Avg Vol (3m): | 76,068.3 |
| Market Cap: | 81.38M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.54 |
| Div & Yield: | N/A (N/A) |
| Tue, Jan 5 | Aryx gets FDA guidance on blood clot drug that failed trialat bizjournals.com |
| Tue, Jan 5 | ARYX THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Tue, Jan 5 | ARYx Therapeutics Receives Guidance on Anticoagulant Agent TecarfarinBusiness Wire |
| Wed, Nov 18 | ARYX THERAPEUTICS, INC. FinancialsEDGAR Online Financials |
| Wed, Nov 18 | Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart AssociationBusiness Wire |
| Sun, Nov 15 | New Star Analyst Rankings for ARYx Therapeutics, Inc.StarMine |
| Fri, Nov 13 | ARYX THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Thu, Nov 12 | Aryx Therapeutics reports $8.2M lossat bizjournals.com |
| Thu, Nov 12 | ARYx Therapeutics Reports Third Quarter 2009 ResultsBusiness Wire |
| Thu, Nov 12 | Q3 2009 ARYx Therapeutics Earnings Release - Time Not SuppliedCCBN |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.